Aimovig (Erenumab)

Brand Options

arrow pointer

Brand Name : Aimovig

Marketing Authorization Holder : Novartis

Prescription Required

Temp Controlled Express Courier

 
 
No Generic Medicine available for this medicine.

Product Details

Aimovig

Aimovig 70mg prefilled syringes are called Suviray internationally.  We ship Aimovig manufactured in the USA with a minimum order quantity of 6 syringes at a time as the cost to ship by cold chain is included in the price.

 

Surivay/Amovig are manufactured at: Amgen Manufacturing Ltd, State Road 31,Km 24.6, Juncos 00777-4060, PUERTO RICO USA

Information About AIMOVIG (Erenumab): 

AIMOVIG (Erenumab) is a medication used for the prevention of migraine headaches in adults, it contain active ingredient erenumab. Aimovig is a sterile, preservative-free solution that is clear to opalescent, ranging in color from colorless to yellowish, and is practically free from particles.

AIMOVIG is solution for injection come in pre-filled pen. AIMOVIG is not suitable for children under age 18. Aimovig should be started to taken under the supervision of a neurologist or a specialist experienced in migraine management. 

Product Highlights

  • AIMOVIG is a monoclonal antibody that targets the calcitonin gene-related peptide receptor (CGRP-R).
  • It is specifically designed for the prevention of migraine attacks.
  • It is administered as a single injection under the skin.

Direction of Use:

  • Administered as a subcutaneous injection once a month.
  • Dosage and frequency may vary based on individual patient response and healthcare provider recommendations.

Key Benefits

  • Reduces the frequency and severity of migraine attacks.
  • Helps improve quality of life by reducing migraine-related disability.
  • Aimovig works by blocking the activity of the CGRP molecule, which is associated with migraine.

Key Ingredient:

  • Erenumab
  • Sucrose
  • Polysorbate 80
  • Sodium hydroxide
  • Glacial acetic acid
  • Water for injections.

Safety Concern

  • May cause injection site reactions (e.g., redness, swelling, pain).
  • Potential for allergic reactions; monitor for signs such as rash, itching, or difficulty breathing.
  • Considerations regarding cardiovascular risk should be evaluated before starting treatment.

Avoid Taking AIMOVIG (Erenumab) If:

  • Allergic to Erenumab or any of its components.
  • Have a history of severe allergic reactions to other monoclonal antibodies.
  • Pregnant or planning to become pregnant without consulting a healthcare provider due to potential risks to the fetus.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.

The product may appear different from
the product illustrated here



Image Image Image Image